




版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡介
膽堿受體阻斷藥CholinoceptorBlockingDrugs成都大學(xué)醫(yī)護(hù)學(xué)院藥理教研室王躍锜原創(chuàng)膽堿受體阻斷藥CholinoceptorBlocking1
MuscarinicCholinoceptorBlockingDrugs
毒蕈堿型受體阻斷藥,M受體阻斷藥2NicotinicCholinoceptorBlockingDrugs
煙堿型受體阻斷藥,N受體阻斷藥IntroductiontoCholinoceptorBlockingDrugs
膽堿受體阻斷藥1MuscarinicCholinoceptorBloMuscarinicCholinoceptorBlockingDrugs毒蕈堿型受體阻斷藥,M受體阻斷藥ReceptorTypeOtherNamesLocation部位M1
Nerves神經(jīng)M2
CardiacM2
Heart,nerves,smoothmuscle心臟,神經(jīng),平滑肌M3
Glands,smoothmuscle,endothelium腺體,平滑肌,內(nèi)皮細(xì)胞M4
CNS中樞神經(jīng)系統(tǒng)M5
CNSNM
Muscletype,endplatereceptor肌肉型,終板受體Skeletalmuscleneuromuscularjunction骨骼肌神經(jīng)肌肉接頭NN
Neuronaltype,ganglionreceptor神經(jīng)元型,神經(jīng)節(jié)受體postganglioniccellbody,dendrites突觸后細(xì)胞,樹突MuscarinicCholinoceptorBlockAtropine阿托品tertiaryaminealkaloidestersoftropicacid莨菪酸的叔胺生物堿酯Propantheline丙胺太林,普魯本辛Quaternaryamineantimuscarinicagents季胺類化合物Atropine阿托品tertiaryaminealkMosttertiaryantimuscarinicdrugs(叔胺類抗膽堿藥)
arewellabsorbedfromthegut(消化道)
andconjunctivalmembranes(結(jié)膜).Incontrast,only10–30%ofadoseofaquaternaryantimuscarinicdrug(季胺類抗膽堿藥)
isabsorbedafteroraladministration(口服),reflectingthedecreasedlipidsolubilityofthechargedmolecule(帶電荷的分子).Absorption吸收
MosttertiaryantimuscarinicdDistribution分布
Atropineandtheothertertiaryagents(叔胺類抗膽堿藥)arewidelydistributedinthebody.SignificantlevelsareachievedintheCNS(中樞神經(jīng)系統(tǒng))within30minutesto1hour,andthiscanlimitthedosetoleratedwhenthedrugistakenforitsperipheraleffects.Scopolamine(東莨菪堿)israpidlyandfullydistributedintotheCNSwhereithasgreatereffectsthanmostotherantimuscarinicdrugs.Incontrast,thequaternaryderivatives(季胺類抗膽堿藥)arepoorlytakenupbythebrainandthereforearerelativelyfree—atlowdoses—ofCNSeffects.Distribution分布AtropineandAfteradministration,theelimination消除ofatropinefromthebloodoccursinapproximately15hours.About50%ofthedoseisexcretedunchangedintheurine尿.Mostoftherestappearsintheurineashydrolysis水解andconjugationproducts結(jié)合物.Thedrug‘seffectonparasympathetic副交感functiondeclinesrapidlyinallorgansexcepttheeye.Effectsontheiris瞳孔andciliarymuscle睫狀肌persistformorethan72hours.MetabolismandExcretion代謝與消除Afteradministration,theelimAtropinecausesreversible(surmountable可逆的)blockadeatmuscarinicreceptors;thatis,blockadebyasmalldoseofatropinecanbeovercomebyalargerconcentrationofacetylcholine乙酰膽堿
orequivalentmuscarinicagonistM受體阻斷藥.Tissues組織mostsensitivetoatropinearethesalivary唾液腺,bronchial支氣管,andsweatglands汗腺.Secretionofacidbythegastricparietalcells胃壁細(xì)胞
istheleastsensitive.Pharmacodynamics藥效作用Atropinecausesreversible(suAtropineishighlyselective選擇性formuscarinicreceptorsM型受體.Itspotency效力atnicotinicreceptorsN型受體ismuchlower.Atropinedoesnotdistinguish區(qū)分
amongtheM1,M2,andM3subgroups亞型
ofmuscarinicreceptors.Incontrast,otherantimuscarinicdrugsaremoderatelyselectiveforoneoranotherofthesesubgroups.Atropineishighlyselective選CentralNervousSystem中樞神經(jīng)系統(tǒng)
Inthedosesusuallyused,atropine阿托品
hasminimalstimulanteffects興奮效應(yīng)
ontheCNS,andaslower,longer-lastingsedative鎮(zhèn)靜effectonthebrain.Scopolamine東莨菪堿hasmoremarkedcentraleffects,producingdrowsiness嗜睡whengiveninrecommendeddosagesandamnesia失憶insensitiveindividuals.Intoxicdoses中毒劑量,scopolamine,andtoalesserdegreeatropine,cancauseexcitement興奮,agitation
焦躁,hallucinations幻覺,andcoma昏迷.Pharmacodynamics:藥效
器官效應(yīng)OrganSystemEffectsCentralNervousSystem中樞神經(jīng)系統(tǒng)PEye眼前房角變窄睫狀肌松弛擴(kuò)瞳畏光,調(diào)節(jié)麻痹房水回流受阻淚腺分泌減少,眼干澀Eye眼前房角變窄淚腺分泌減少,眼干澀CardiovascularSystem心血管系統(tǒng)心率上升,房室傳導(dǎo)加快CardiovascularSystem心率上升,房室傳導(dǎo)RespiratorySystem呼吸系統(tǒng)支氣管分泌減少,支氣管擴(kuò)張RespiratorySystem呼吸系統(tǒng)支氣管分泌減GastrointestinalTract消化道Blockadeofmuscarinicreceptorshasdramaticeffectsonmotility運(yùn)動
andsomeofthesecretory分泌functionsofthegut腸道.AntimuscarinicdrugsM型抗膽堿藥
havemarkedeffectsonsalivarysecretion唾液分泌;
drymouthoccursfrequentlyinpatientstakingantimuscarinicdrugs.Gastricsecretion胃酸分泌isblockedlesseffectively.Gastrointestinalsmoothmusclemotility胃腸平滑肌運(yùn)動isaffectedfromthestomach胃tothecolon結(jié)腸.Ingeneral,thewallsoftheviscera內(nèi)臟
arerelaxed,andbothtone張力
andpropulsivemovements蠕動arediminished.Therefore,gastricemptyingtime胃排空時間
isprolonged,andintestinaltransittimeislengthened.GastrointestinalTract消化道GenitourinaryTract泌尿道Theantimuscarinicactionofatropineanditsanalogs同類藥
relaxessmoothmuscleoftheureters輸尿管
andbladderwall膀胱壁andslowsvoiding排尿.
SweatGlands汗腺體溫上升,皮膚血流增加散熱降低皮膚變干汗液減少GenitourinaryTractSweatGlanOphthalmologicDisorders
眼科Accuratemeasurementofrefractiveerror屈光不正
inuncooperativepatients,eg,youngchildren,requiresciliaryparalysis睫狀肌麻痹.Also,ophthalmoscopicexamination眼底鏡檢查oftheretina視網(wǎng)膜isgreatlyfacilitatedbymydriasis散瞳.Therefore,antimuscarinicagents,administeredtopicallyaseyedrops眼藥水orointment眼膏,areveryhelpfulindoingacompleteexamination.Foradultsandolderchildren,theshorter-actingdrugsarepreferred(如后馬托品,托吡卡胺).Foryoungerchildren,thegreaterefficacyofatropineissometimesnecessary.Asecondophthalmologicuseistopreventsynechia(adhesion粘連)formationinuveitis葡萄膜炎andiritis虹膜炎.Clinicalapplications臨床應(yīng)用OphthalmologicDisorders眼科ClAntimuscarinicDrugsUsedinOphthalmology眼科使用的M型抗膽堿藥DrugDurationofEffect(days)作用持續(xù)時間UsualConcentration(%)常用濃度Atropine阿托品7–100.5–1Scopolamine東莨菪堿3–70.25Homatropine后馬托品1–32–5Tropicamide托吡卡胺0.250.5–1AntimuscarinicDrugsUsedinORespiratoryDisorders呼吸系統(tǒng)Theuseofatropine阿托品becamepartofroutinepreoperativemedication術(shù)前給藥whenanesthetics麻醉suchasether乙醚wereused,becausetheseirritant刺激性anestheticsmarkedlyincreasedairwaysecretions分泌andwereassociatedwithfrequentepisodesoflaryngospasm喉痙攣.Preanesthetic麻醉前injectionofatropine阿托品
orscopolamine東莨菪堿
couldpreventthesehazardouseffects.RespiratoryDisorders呼吸系統(tǒng)CardiovascularDisorders
心血管系統(tǒng)Markedreflexvagaldischarge迷走神經(jīng)反射性興奮
sometimesaccompaniesthepainofmyocardialinfarction心肌梗塞(eg,vasovagalattack血管迷走神經(jīng)性發(fā)作)andmayimpaircardiacoutput心輸出.Parenteral注射atropineorasimilarantimuscarinicdrugisappropriatetherapyinthissituation.Rareindividualswithoutotherdetectablecardiacdiseasehavehyperactivecarotidsinusreflexes頸動脈竇反射andmayexperiencefaintness眩暈
orevensyncope昏厥asaresultofvagaldischarge迷走興奮
inresponsetopressureontheneck,eg,fromatightcollar.Suchindividualsmaybenefitfromtheuseofatropineorarelatedantimuscarinicagent.CardiovascularDisorders心血管系GastrointestinalDisorders
消化道Antimuscarinicagentscanprovidesomereliefinthetreatmentofmildorself-limitedconditionsofhypermotility胃腸平滑肌過度興奮.UrinaryDisorders
泌尿系統(tǒng)Atropineandotherantimuscarinicdrugshavebeenusedtoprovidesymptomaticreliefinthetreatmentofurinaryurgency尿急causedbyminorinflammatorybladderdisorders膀胱炎.GastrointestinalDisorders消化CholinergicPoisoning
膽堿能中毒Severecholinergicexcessisamedicalemergency,especiallyinruralcommunitieswherecholinesteraseinhibitorinsecticides殺蟲劑arecommonlyusedandincultureswherewildmushrooms毒蘑菇arecommonlyeaten.Thepotentialuseofcholinesteraseinhibitorsaschemicalwarfare“nervegases“神經(jīng)毒氣
alsorequiresanawarenessofthemethodsfortreatingacutepoisoning.CholinergicPoisoning膽堿能中毒Overdoses過量ofatropineoritscongeners同類藥aregenerallytreatedsymptomatically對癥治療.Poisoncontrolexpertsdiscouragetheuseofphysostigmine毒扁豆堿oranothercholinesteraseinhibitor膽堿酯酶抑制藥toreversetheeffectsofatropineoverdosebecausesymptomaticmanagementismoreeffectiveandlessdangerous.Symptomatictreatmentmayrequiretemperaturecontrolwithcoolingblanketsandseizure癲癇controlwithdiazepam安定.Artificialrespiratorysupportisneededinrespiratorydepression.AntimuscarinicPoisoning抗膽堿藥中毒Overdoses過量ofatropineoritsContraindicationstotheuseofantimuscarinicdrugsarerelative相對禁忌,notabsolute.Obviousmuscarinicexcess,especiallythatcausedbycholinesteraseinhibitors膽堿酯酶抑制藥,canalwaysbetreatedwithatropine.Antimuscarinicdrugsarecontraindicatedinpatientswithglaucoma青光眼,especiallyangle-closureglaucoma急性閉角型青光眼.Inelderlymen,antimuscarinicdrugsshouldalwaysbeusedwithcautionandshouldbeavoidedinthosewithahistoryofprostatichyperplasia
前列腺肥大.Contraindications禁忌癥Contraindicationstotheuseo1Ganglionicblockingdrugs
神經(jīng)節(jié)阻斷藥2Skeletalmuscularrelaxants
骨骼肌松弛劑Nicotiniccholinoceptor
blockingdrugs煙堿型受體阻斷藥N受體阻斷藥1GanglionicblockingdrugsNicGanglionicblockingdrugs
神經(jīng)節(jié)阻斷藥GanglionPreganglionicfiberPostganglionicfiberGanglionicblockingdrugs
神經(jīng)節(jié)阻Mecamylamine美加明andtrimethaphan咪噻吩isoccasionallyusedinthetreatmentofhypertensiveemergencies高血壓危象anddissectingaorticaneurysm主動脈夾層動脈瘤;inproducinghypotension低血壓,whichcanbeofvalueinneurosurgery神經(jīng)手術(shù)toreducebleedingintheoperativefield.Clinicalapplications臨床應(yīng)用Mecamylamine美加明andtrimethaphaNeuromuscularblockingdrugsinterferewithtransmissionattheneuromuscularendplate終板.Thesecompoundsareusedprimarilyasadjuncts輔助用藥duringgeneralanesthesia全身麻醉tofacilitatetrachealintubation氣管插管andoptimizesurgicalconditionswhileensuringadequateventilation通氣.Skeletalmuscularrelaxants
骨骼肌松弛劑NeuromuscularblockingdrugsiMechanismofneuromuscularblocked作用機(jī)制Mechanismofneuromuscularblo1Nondepolarizingmuscularrelaxants(d-tubocurarine筒箭毒堿)
非除極化肌松藥2Depolarizingmuscularrelaxants(succinylcholine琥珀酰膽堿)
除極化肌松藥1Nondepolarizingmuscularrel筒箭毒堿Nondepolarizingmuscularrelaxants非除極化肌松藥筒箭毒堿Nondepolarizingmuscularr膽堿受體阻斷藥課件Duringanesthesia麻醉,administrationoftubocurarine筒箭毒堿initiallycausesmotorweakness,followedbytheskeletalmusclesbecomingflaccid松弛的andinexcitabletoelectricalstimulation.Ingeneral,largermuscles(eg,abdominal腹肌,trunk軀干,diaphragm)橫隔膜aremoreresistanttoneuromuscularblockadeandrecovermorerapidlythansmallermuscles(eg,facial面部,foot,hand).Thediaphragm膈肌
isusuallythelastmuscletobeparalyzed麻痹.Whenadministrationofmusclerelaxantsisdiscontinued,recoveryofmusclesusuallyoccursinreverseorder,withthediaphragmregainingfunctionfirst.Clinicalapplications臨床應(yīng)用Duringanesthesia麻醉,administr乙酰膽堿Depolarizingmuscularrelaxants
除極化肌松藥琥珀酰膽堿乙酰膽堿Depolarizingmuscularrela膽堿受體阻斷藥課件Followingtheadministrationofsuccinylcholine琥珀酰膽堿,transientmusclefasciculations肌束震顫
occuroverthechest胸部andabdomen腹部within30seconds.Asparalysis麻痹developsrapidly(<90seconds),thearm,neck,andlegmusclesareinitiallyrelaxedfollowedbytherespiratorymuscles呼吸肌.Asaresultofsuccinylcholine‘srapidhydrolysis水解bycholinesteraseintheplasma血漿(andliver),thedurationofneuromuscularblocktypicallylastslessthan10minutes.Clinicalapplications臨床應(yīng)用FollowingtheadministrationoTubocurarine筒箭毒堿Succinylcholine琥珀酰膽堿PhaseIPhaseIIEffectofneostigmine新斯的明的影響AntagonisticAugmented1
AntagonisticInitialexcitatoryeffectonskeletalmuscle骨骼肌初始的表現(xiàn)NoneFasciculations肌束震顫NoneTubocurarineSuccinylcholine琥A63-year-oldarchitect,complainsofurinarysymptomstohisfamilyphysician.Hehashypertensionandthelast8years,hehasbeenadequatelymanagedwithathiazidediuretic噻嗪類利尿藥andanangiotensin-convertingenzymeinhibitor.Duringthesameperiod,hedevelopedthesignsofbenignprostatichypertrophy,whicheventuallyrequiredprostatectomy前列腺切除torelievesymptoms.Henowcomplainsthathehasanincreasedurgetourinateaswellasurinaryfrequency,andthishasdisruptedthepatternofhisdailylife.Whattreatmentstepswouldyouinitiate?CaseStudyA63-year-oldarchitect,complA53-year-oldwomancomestoseeyouforaconsultation.SheisscheduledtotakeaCaribbeancruisein2weeksbutisconcernedaboutseasickness.Shehasbeenonboatsbeforeandisverysensitivetomotionsickness.Afriendmentionedtoherthatthereisapatchthatiseffectiveforthisproblem.Sheisingoodhealthandtakesnomedicationsregularly.Herexaminationisnormal.Youprescribeascopolaminetransdermalpatchforher.
·Whatisthemechanismofactionofscopolamine?
·Whatarethecommonsideeffectsofthismedication?
·Whataresomerelativecontraindicationstoitsuse?CaseStudyA53-year-oldwomancomestosMechanismofactionofscopolamine:Competitiveantagonistofmuscariniccholinoreceptorsinthevestibularsystemandthecentralnervoussystem(CNS).
Commonsideeffects:Mydriasis,drymouth,tachycardia,urinaryretention,confusion,drowsiness.
Relativecontraindications:Glaucoma,urinaryobstruction,heartdisease.
ANSWERSTOCASEMechanismofactionofscopola膽堿受體阻斷藥CholinoceptorBlockingDrugs成都大學(xué)醫(yī)護(hù)學(xué)院藥理教研室王躍锜原創(chuàng)膽堿受體阻斷藥CholinoceptorBlocking1
MuscarinicCholinoceptorBlockingDrugs
毒蕈堿型受體阻斷藥,M受體阻斷藥2NicotinicCholinoceptorBlockingDrugs
煙堿型受體阻斷藥,N受體阻斷藥IntroductiontoCholinoceptorBlockingDrugs
膽堿受體阻斷藥1MuscarinicCholinoceptorBloMuscarinicCholinoceptorBlockingDrugs毒蕈堿型受體阻斷藥,M受體阻斷藥ReceptorTypeOtherNamesLocation部位M1
Nerves神經(jīng)M2
CardiacM2
Heart,nerves,smoothmuscle心臟,神經(jīng),平滑肌M3
Glands,smoothmuscle,endothelium腺體,平滑肌,內(nèi)皮細(xì)胞M4
CNS中樞神經(jīng)系統(tǒng)M5
CNSNM
Muscletype,endplatereceptor肌肉型,終板受體Skeletalmuscleneuromuscularjunction骨骼肌神經(jīng)肌肉接頭NN
Neuronaltype,ganglionreceptor神經(jīng)元型,神經(jīng)節(jié)受體postganglioniccellbody,dendrites突觸后細(xì)胞,樹突MuscarinicCholinoceptorBlockAtropine阿托品tertiaryaminealkaloidestersoftropicacid莨菪酸的叔胺生物堿酯Propantheline丙胺太林,普魯本辛Quaternaryamineantimuscarinicagents季胺類化合物Atropine阿托品tertiaryaminealkMosttertiaryantimuscarinicdrugs(叔胺類抗膽堿藥)
arewellabsorbedfromthegut(消化道)
andconjunctivalmembranes(結(jié)膜).Incontrast,only10–30%ofadoseofaquaternaryantimuscarinicdrug(季胺類抗膽堿藥)
isabsorbedafteroraladministration(口服),reflectingthedecreasedlipidsolubilityofthechargedmolecule(帶電荷的分子).Absorption吸收
MosttertiaryantimuscarinicdDistribution分布
Atropineandtheothertertiaryagents(叔胺類抗膽堿藥)arewidelydistributedinthebody.SignificantlevelsareachievedintheCNS(中樞神經(jīng)系統(tǒng))within30minutesto1hour,andthiscanlimitthedosetoleratedwhenthedrugistakenforitsperipheraleffects.Scopolamine(東莨菪堿)israpidlyandfullydistributedintotheCNSwhereithasgreatereffectsthanmostotherantimuscarinicdrugs.Incontrast,thequaternaryderivatives(季胺類抗膽堿藥)arepoorlytakenupbythebrainandthereforearerelativelyfree—atlowdoses—ofCNSeffects.Distribution分布AtropineandAfteradministration,theelimination消除ofatropinefromthebloodoccursinapproximately15hours.About50%ofthedoseisexcretedunchangedintheurine尿.Mostoftherestappearsintheurineashydrolysis水解andconjugationproducts結(jié)合物.Thedrug‘seffectonparasympathetic副交感functiondeclinesrapidlyinallorgansexcepttheeye.Effectsontheiris瞳孔andciliarymuscle睫狀肌persistformorethan72hours.MetabolismandExcretion代謝與消除Afteradministration,theelimAtropinecausesreversible(surmountable可逆的)blockadeatmuscarinicreceptors;thatis,blockadebyasmalldoseofatropinecanbeovercomebyalargerconcentrationofacetylcholine乙酰膽堿
orequivalentmuscarinicagonistM受體阻斷藥.Tissues組織mostsensitivetoatropinearethesalivary唾液腺,bronchial支氣管,andsweatglands汗腺.Secretionofacidbythegastricparietalcells胃壁細(xì)胞
istheleastsensitive.Pharmacodynamics藥效作用Atropinecausesreversible(suAtropineishighlyselective選擇性formuscarinicreceptorsM型受體.Itspotency效力atnicotinicreceptorsN型受體ismuchlower.Atropinedoesnotdistinguish區(qū)分
amongtheM1,M2,andM3subgroups亞型
ofmuscarinicreceptors.Incontrast,otherantimuscarinicdrugsaremoderatelyselectiveforoneoranotherofthesesubgroups.Atropineishighlyselective選CentralNervousSystem中樞神經(jīng)系統(tǒng)
Inthedosesusuallyused,atropine阿托品
hasminimalstimulanteffects興奮效應(yīng)
ontheCNS,andaslower,longer-lastingsedative鎮(zhèn)靜effectonthebrain.Scopolamine東莨菪堿hasmoremarkedcentraleffects,producingdrowsiness嗜睡whengiveninrecommendeddosagesandamnesia失憶insensitiveindividuals.Intoxicdoses中毒劑量,scopolamine,andtoalesserdegreeatropine,cancauseexcitement興奮,agitation
焦躁,hallucinations幻覺,andcoma昏迷.Pharmacodynamics:藥效
器官效應(yīng)OrganSystemEffectsCentralNervousSystem中樞神經(jīng)系統(tǒng)PEye眼前房角變窄睫狀肌松弛擴(kuò)瞳畏光,調(diào)節(jié)麻痹房水回流受阻淚腺分泌減少,眼干澀Eye眼前房角變窄淚腺分泌減少,眼干澀CardiovascularSystem心血管系統(tǒng)心率上升,房室傳導(dǎo)加快CardiovascularSystem心率上升,房室傳導(dǎo)RespiratorySystem呼吸系統(tǒng)支氣管分泌減少,支氣管擴(kuò)張RespiratorySystem呼吸系統(tǒng)支氣管分泌減GastrointestinalTract消化道Blockadeofmuscarinicreceptorshasdramaticeffectsonmotility運(yùn)動
andsomeofthesecretory分泌functionsofthegut腸道.AntimuscarinicdrugsM型抗膽堿藥
havemarkedeffectsonsalivarysecretion唾液分泌;
drymouthoccursfrequentlyinpatientstakingantimuscarinicdrugs.Gastricsecretion胃酸分泌isblockedlesseffectively.Gastrointestinalsmoothmusclemotility胃腸平滑肌運(yùn)動isaffectedfromthestomach胃tothecolon結(jié)腸.Ingeneral,thewallsoftheviscera內(nèi)臟
arerelaxed,andbothtone張力
andpropulsivemovements蠕動arediminished.Therefore,gastricemptyingtime胃排空時間
isprolonged,andintestinaltransittimeislengthened.GastrointestinalTract消化道GenitourinaryTract泌尿道Theantimuscarinicactionofatropineanditsanalogs同類藥
relaxessmoothmuscleoftheureters輸尿管
andbladderwall膀胱壁andslowsvoiding排尿.
SweatGlands汗腺體溫上升,皮膚血流增加散熱降低皮膚變干汗液減少GenitourinaryTractSweatGlanOphthalmologicDisorders
眼科Accuratemeasurementofrefractiveerror屈光不正
inuncooperativepatients,eg,youngchildren,requiresciliaryparalysis睫狀肌麻痹.Also,ophthalmoscopicexamination眼底鏡檢查oftheretina視網(wǎng)膜isgreatlyfacilitatedbymydriasis散瞳.Therefore,antimuscarinicagents,administeredtopicallyaseyedrops眼藥水orointment眼膏,areveryhelpfulindoingacompleteexamination.Foradultsandolderchildren,theshorter-actingdrugsarepreferred(如后馬托品,托吡卡胺).Foryoungerchildren,thegreaterefficacyofatropineissometimesnecessary.Asecondophthalmologicuseistopreventsynechia(adhesion粘連)formationinuveitis葡萄膜炎andiritis虹膜炎.Clinicalapplications臨床應(yīng)用OphthalmologicDisorders眼科ClAntimuscarinicDrugsUsedinOphthalmology眼科使用的M型抗膽堿藥DrugDurationofEffect(days)作用持續(xù)時間UsualConcentration(%)常用濃度Atropine阿托品7–100.5–1Scopolamine東莨菪堿3–70.25Homatropine后馬托品1–32–5Tropicamide托吡卡胺0.250.5–1AntimuscarinicDrugsUsedinORespiratoryDisorders呼吸系統(tǒng)Theuseofatropine阿托品becamepartofroutinepreoperativemedication術(shù)前給藥whenanesthetics麻醉suchasether乙醚wereused,becausetheseirritant刺激性anestheticsmarkedlyincreasedairwaysecretions分泌andwereassociatedwithfrequentepisodesoflaryngospasm喉痙攣.Preanesthetic麻醉前injectionofatropine阿托品
orscopolamine東莨菪堿
couldpreventthesehazardouseffects.RespiratoryDisorders呼吸系統(tǒng)CardiovascularDisorders
心血管系統(tǒng)Markedreflexvagaldischarge迷走神經(jīng)反射性興奮
sometimesaccompaniesthepainofmyocardialinfarction心肌梗塞(eg,vasovagalattack血管迷走神經(jīng)性發(fā)作)andmayimpaircardiacoutput心輸出.Parenteral注射atropineorasimilarantimuscarinicdrugisappropriatetherapyinthissituation.Rareindividualswithoutotherdetectablecardiacdiseasehavehyperactivecarotidsinusreflexes頸動脈竇反射andmayexperiencefaintness眩暈
orevensyncope昏厥asaresultofvagaldischarge迷走興奮
inresponsetopressureontheneck,eg,fromatightcollar.Suchindividualsmaybenefitfromtheuseofatropineorarelatedantimuscarinicagent.CardiovascularDisorders心血管系GastrointestinalDisorders
消化道Antimuscarinicagentscanprovidesomereliefinthetreatmentofmildorself-limitedconditionsofhypermotility胃腸平滑肌過度興奮.UrinaryDisorders
泌尿系統(tǒng)Atropineandotherantimuscarinicdrugshavebeenusedtoprovidesymptomaticreliefinthetreatmentofurinaryurgency尿急causedbyminorinflammatorybladderdisorders膀胱炎.GastrointestinalDisorders消化CholinergicPoisoning
膽堿能中毒Severecholinergicexcessisamedicalemergency,especiallyinruralcommunitieswherecholinesteraseinhibitorinsecticides殺蟲劑arecommonlyusedandincultureswherewildmushrooms毒蘑菇arecommonlyeaten.Thepotentialuseofcholinesteraseinhibitorsaschemicalwarfare“nervegases“神經(jīng)毒氣
alsorequiresanawarenessofthemethodsfortreatingacutepoisoning.CholinergicPoisoning膽堿能中毒Overdoses過量ofatropineoritscongeners同類藥aregenerallytreatedsymptomatically對癥治療.Poisoncontrolexpertsdiscouragetheuseofphysostigmine毒扁豆堿oranothercholinesteraseinhibitor膽堿酯酶抑制藥toreversetheeffectsofatropineoverdosebecausesymptomaticmanagementismoreeffectiveandlessdangerous.Symptomatictreatmentmayrequiretemperaturecontrolwithcoolingblanketsandseizure癲癇controlwithdiazepam安定.Artificialrespiratorysupportisneededinrespiratorydepression.AntimuscarinicPoisoning抗膽堿藥中毒Overdoses過量ofatropineoritsContraindicationstotheuseofantimuscarinicdrugsarerelative相對禁忌,notabsolute.Obviousmuscarinicexcess,especiallythatcausedbycholinesteraseinhibitors膽堿酯酶抑制藥,canalwaysbetreatedwithatropine.Antimuscarinicdrugsarecontraindicatedinpatientswithglaucoma青光眼,especiallyangle-closureglaucoma急性閉角型青光眼.Inelderlymen,antimuscarinicdrugsshouldalwaysbeusedwithcautionandshouldbeavoidedinthosewithahistoryofprostatichyperplasia
前列腺肥大.Contraindications禁忌癥Contraindicationstotheuseo1Ganglionicblockingdrugs
神經(jīng)節(jié)阻斷藥2Skeletalmuscularrelaxants
骨骼肌松弛劑Nicotiniccholinoceptor
blockingdrugs煙堿型受體阻斷藥N受體阻斷藥1GanglionicblockingdrugsNicGanglionicblockingdrugs
神經(jīng)節(jié)阻斷藥GanglionPreganglionicfiberPostganglionicfiberGanglionicblockingdrugs
神經(jīng)節(jié)阻Mecamylamine美加明andtrimethaphan咪噻吩isoccasionallyusedinthetreatmentofhypertensiveemergencies高血壓危象anddissectingaorticaneurysm主動脈夾層動脈瘤;inproducinghypotension低血壓,whichcanbeofvalueinneurosurgery神經(jīng)手術(shù)toreducebleedingintheoperativefield.Clinicalapplications臨床應(yīng)用Mecamylamine美加明andtrimethaphaNeuromuscularblockingdrugsinterferewithtransmissionattheneuromuscularendplate終板.Thesecompoundsareusedprimarilyasadjuncts輔助用藥duringgeneralanesthesia全身麻醉tofacilitatetrachealintubation氣管插管andoptimizesurgicalconditionswhileensuringadequateventilation通氣.Skeletalmuscularrelaxants
骨骼肌松弛劑NeuromuscularblockingdrugsiMechanismofneuromuscularblocked作用機(jī)制Mechanismofneuromuscularblo1Nondepolarizingmuscularrelaxants(d-tubocurarine筒箭毒堿)
非除極化肌松藥2Depolarizingmuscularrelaxants(succinylcholine琥珀酰膽堿)
除極化肌松藥1Nondepolarizingmuscularrel筒箭毒堿Nondepolarizingmuscularrelaxants非除極化肌松藥筒箭毒堿Nondepolarizingmuscularr膽堿受體阻斷藥課件Duringanesthesia麻醉,administrationoftubocurarine筒箭毒堿initiallycausesmotorweakness,followedbytheskeletalmusclesbecomingflaccid松弛的andinexcitabletoelectricalstimulation.Ingeneral,largermuscles(eg,abdominal腹肌,trunk軀干,diaphragm)橫隔膜aremoreresistanttoneuromuscularblockadeandrecovermorerapidlythansmallermuscles(eg,facial面部,foot,hand).Thediaphragm膈肌
isusuallythelastmuscletobeparalyzed麻痹.
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- emc買斷合同范本
- 代款合作合同范本
- 2025年抗風(fēng)濕類藥品合作協(xié)議書
- 合同范本網(wǎng)翻譯
- 合同范本全是正式合同
- 雙方交付款合同范例
- 2025年分離純化控制系統(tǒng)項(xiàng)目合作計(jì)劃書
- 中英日文合同范本
- 合同范本模板去石墻
- 叉車置換銷售合同范本
- 約束評分標(biāo)準(zhǔn)
- GB/T 28799.2-2020冷熱水用耐熱聚乙烯(PE-RT)管道系統(tǒng)第2部分:管材
- 法律和道德的關(guān)系 課件
- GB 16780-2021水泥單位產(chǎn)品能源消耗限額
- 2023-瑞幸咖啡vi手冊
- 全面推進(jìn)依法行政課件
- 政務(wù)服務(wù)一網(wǎng)通辦平臺解決方案-最新
- IPC-7351表面貼裝設(shè)計(jì)和焊盤圖形標(biāo)準(zhǔn)
- 第十四屆全國交通運(yùn)輸行業(yè)職業(yè)技能競賽(公路收費(fèi)及監(jiān)控員)賽項(xiàng)題庫-上(單選題匯總-共3部分-1)
- NBT 10664-2021 核電廠工程巖土試驗(yàn)規(guī)程
- 醫(yī)院產(chǎn)前篩查中心設(shè)置評審驗(yàn)收工作匯報(bào)課件
評論
0/150
提交評論